🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Invokana

Found 182 matching trials

A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics, Pharmacodynamics, and Safety of Glyburide in Healthy Volunteers

PHASE1

The purpose of this study is to determine how multiple doses of canaglifloz...

Status

Completed

Location

Multiple Locations

Start Date

2008-07

Trial ID

NCT01733108

Treatments Being Tested

Glyburide Canagliflozin (JNJ-28431754)

Canagliflozin-Mealtime Insulin Rescue

PHASE4

24-week, randomized, double blind, placebo-controlled trial to evaluate saf...

Status

Unknown

Location

Atlanta VA Medical Center

Start Date

2016-01

Trial ID

NCT02624908

Treatments Being Tested

canagliflozin placebo

Bioequivalence Study of Metformin Component of Fixed Dose Combination (FDC) Immediate Release (IR) Tablet of Canagliflozin and Metformin Compared to Metformin IR Tablet Co-administered With Canagliflozin in Healthy Fed and Fasted Participants

PHASE1

The purpose of this study is to evaluate the bioequivalence of metformin co...

Status

Completed

Location

Multiple Locations

Start Date

2014-08

Trial ID

NCT02221180

Treatments Being Tested

Canagliflozin and Metformin Immediate Release (IR) Fixed Dose Combination [FDC]Canagliflozin Metformin

A Study to Assess the Bioequivalence of Fixed Dose Combination (FDC) Tablets of Canagliflozin and Metformin Immediate Release (IR) With Respect to the Individual Components of Canagliflozin and Metformin IR Tablets in Healthy Volunteers

PHASE1

The purpose of this study is to evaluate the bioequivalence of a fixed dose...

Status

Completed

Location

Multiple Locations

Start Date

2011-09

Trial ID

NCT01463228

Treatments Being Tested

A (canagliflozin and metformin IR individual tablets) / B (canagliflozin/metformin IR FDC tablets)B (canagliflozin/metformin IR FDC tablets / A (canagliflozin and metformin IR individual tablets)

Metabolic and Cardiovascular Effects of Dipeptidyl Peptidase-4 (DPP-4) or Sodium-glucose Co-transporter Type 2 (SGLT2) Inhibitors

PHASE4

Inhibition of dipeptidyl peptidase-4 (DPP-4) or sodium-glucose co-transport...

Status

Unknown

Location

Kurume University Hospital

Start Date

2015-08

Trial ID

NCT02528019

Treatments Being Tested

DPP-4 inhibiotors SGLT2 inhibitors Glimepiride

Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND)

PHASE4

BEYOND represents an open-label, parallel, three-arm randomized controlled ...

Status

Completed

Location

Unit of Endocrinology and Metabolic Diseases

Start Date

2019-11-27

Trial ID

NCT04196231

Treatments Being Tested

IDegLira IGlarLixi Insulin/Canaglifozin Insulin/Dapaglifozin Insulin/Empaglifozin Basal Bolus

A Pharmacokinetic and Pharmacodynamic Study of Metformin and Canagliflozin in Healthy Adult Volunteers

PHASE1

The purpose of the study is to investigate the potential interaction betwee...

Status

Completed

Location

Multiple Locations

Start Date

2010-12

Trial ID

NCT01273571

Treatments Being Tested

Canagliflozin/Metformin

A Study to Assess the Bioequivalence of 2 Fixed Dose Combination (FDC) Tablets of Canagliflozin and Metformin Immediate Release (IR) (50 mg/1,000 mg) With Respect to the Individual Components of Canagliflozin (1 x 100 mg) and Metformin IR Tablets (2 x 1,000 mg) in Healthy Volunteers

PHASE1

The purpose of this study is to evaluate the bioequivalence of fixed dose c...

Status

Completed

Location

Multiple Locations

Start Date

2011-09

Trial ID

NCT01454622

Treatments Being Tested

A (canagliflozin and metformin IR individual tablets) / B (canagliflozin/metformin IR FDC tablets)B (canagliflozin/metformin IR FDC tablets / A (canagliflozin and metformin IR individual tablets)

A Drug Interaction Study of Warfarin and Canagliflozin in Healthy Adult Volunteers

PHASE1

The purpose of the study is to assess the effect of multiple oral doses of ...

Status

Completed

Location

Multiple Locations

Start Date

2010-09

Trial ID

NCT01195324

Treatments Being Tested

Canagliflozin/Warfarin Canagliflozin/Warfarin

A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin

PHASE4

The purpose of this study is to assess the effect of canagliflozin (JNJ-284...

Status

Completed

Location

Multiple Locations

Start Date

2014-02

Trial ID

NCT02025907

Treatments Being Tested

Canagliflozin, 100 mg Canagliflozin, 300 mg Placebo

Previous Next